Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea · Delayed Price · Currency is KRW 2,335.00
+75.00 (3.32%)
At close: Aug 18, 2026
Green Lifescience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45,594 | 56,626 | 32,080 | 44,500 | 88,950 | 151,500 | |
Market Cap Growth | -21.11% | 76.52% | -27.91% | -49.97% | -41.29% | -17.55% |
Enterprise Value | 37,276 | 49,529 | 23,531 | 35,603 | 82,140 | 143,836 |
Last Close Price | 2335.00 | 2900.00 | 1604.00 | 2225.00 | 4447.50 | 7575.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.03 | 514.16 | 20.54 | - | - | - |
PS Ratio | 0.89 | 1.40 | 1.29 | 1.99 | 2.44 | 5.98 |
PB Ratio | 1.14 | 1.48 | 0.90 | 1.24 | 1.69 | 2.69 |
P/TBV Ratio | 1.15 | 1.48 | 0.90 | 1.24 | 1.69 | 2.70 |
P/OCF Ratio | - | 155.63 | 61.05 | 120.26 | - | 247.80 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.73 | 1.23 | 0.95 | 1.59 | 2.25 | 5.68 |
EV/EBITDA Ratio | 13.82 | 49.82 | 20.54 | - | - | - |
EV/EBIT Ratio | 19.37 | 242.44 | 62.43 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.18 | 0.15 | 0.14 | 0.13 | 0.14 |
Debt / EBITDA Ratio | 1.95 | 7.03 | 4.69 | - | - | - |
Net Debt / Equity Ratio | -0.21 | -0.27 | -0.21 | -0.26 | -0.20 | -0.15 |
Net Debt / EBITDA Ratio | -3.08 | -10.25 | -6.56 | 4.39 | 8.68 | 4.13 |
Net Debt / FCF Ratio | 2.94 | 20.57 | 29.45 | 75.76 | 1.71 | 3.04 |
Asset Turnover | 1.01 | 0.81 | 0.56 | 0.42 | 0.54 | 0.36 |
Inventory Turnover | 5.43 | 6.15 | 4.75 | 4.36 | 6.45 | 4.46 |
Quick Ratio | 1.47 | 1.51 | 2.16 | 2.15 | 2.10 | 1.30 |
Current Ratio | 2.17 | 2.04 | 2.65 | 2.94 | 2.80 | 1.76 |
Return on Equity (ROE) | 8.07% | 0.30% | 4.36% | -36.93% | -6.47% | -5.42% |
Return on Assets (ROA) | 2.38% | 0.26% | 0.53% | -5.46% | -3.68% | -4.07% |
Return on Invested Capital (ROIC) | 6.43% | 0.73% | 1.38% | -13.51% | -8.79% | -9.45% |
Return on Capital Employed (ROCE) | 4.70% | 0.50% | 1.00% | -12.70% | -7.50% | -8.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.60% | 0.19% | 4.87% | -36.76% | -3.96% | -2.07% |
FCF Yield | -6.21% | -0.88% | -0.80% | -0.28% | -6.78% | -1.87% |
Buyback Yield / Dilution | -1.46% | 0.24% | 3.61% | 0.19% | - | - |